{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:10:23Z","timestamp":1791162623803,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,5,10]]},"DOI":"10.1038\/onc.2011.426","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T12:40:09Z","timestamp":1318855209000},"page":"2412-2422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance"],"prefix":"10.1038","volume":"31","author":[{"given":"W","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,26]]},"reference":[{"key":"BFonc2011426_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mrfmmm.2004.11.016","volume":"571","author":"N Agar","year":"2005","unstructured":"Agar N, Young AR . (2005). Melanogenesis: a photoprotective response to DNA damage? Mutat Res 571: 121\u2013132.","journal-title":"Mutat Res"},{"key":"BFonc2011426_CR2","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1158\/0008-5472.CAN-06-3821","volume":"67","author":"LO Andrieux","year":"2007","unstructured":"Andrieux LO, Fautrel A, Bessard A, Guillouzo A, Baffet G, Langouet S . (2007). GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells. Cancer Res 67: 2114\u20132123.","journal-title":"Cancer Res"},{"key":"BFonc2011426_CR3","doi-asserted-by":"publisher","first-page":"C189","DOI":"10.1152\/ajpcell.00347.2009","volume":"299","author":"O Bermudez","year":"2010","unstructured":"Bermudez O, Pages G, Gimond C . (2010). The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol 299: C189\u2013C202.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFonc2011426_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199707243370406","volume":"337","author":"GJ Bosl","year":"1997","unstructured":"Bosl GJ, Motzer RJ . (1997). Testicular germ-cell cancer. N Engl J Med 337: 242\u2013253.","journal-title":"N Engl J Med"},{"key":"BFonc2011426_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/ijc.2910550428","volume":"55","author":"R Brown","year":"1993","unstructured":"Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B et al. (1993). Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 55: 678\u2013684.","journal-title":"Int J Cancer"},{"key":"BFonc2011426_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.007","volume":"251","author":"A Brozovic","year":"2007","unstructured":"Brozovic A, Osmak M . (2007). Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251: 1\u201316.","journal-title":"Cancer Lett"},{"key":"BFonc2011426_CR7","unstructured":"Cancer Research UK. Cancer Statistics, (2011). http:\/\/info.cancerresearchuk.org\/cancerstats."},{"key":"BFonc2011426_CR8","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/carcin\/bgn167","volume":"29","author":"DW Chan","year":"2008","unstructured":"Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK et al. (2008). Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29: 1742\u20131750.","journal-title":"Carcinogenesis"},{"key":"BFonc2011426_CR9","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","volume":"17","author":"PBL Chapman","year":"1999","unstructured":"Chapman PBL, Einhorn H, Meyers ML, Saxman S, Destro AN, Panageas KS et al. (1999). Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 17: 2745\u20132751.","journal-title":"J Clin Oncol"},{"key":"BFonc2011426_CR10","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364: 2507\u20132516.","journal-title":"N Engl J Med"},{"key":"BFonc2011426_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1593\/neo.09398","volume":"11","author":"L Ciuffreda","year":"2009","unstructured":"Ciuffreda L, Del Bufalo D, Desideri M, Di Sanza C, Stoppacciaro A, Ricciardi MR et al. (2009). Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations. Neoplasia 11: 720\u2013731.","journal-title":"Neoplasia"},{"key":"BFonc2011426_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/BJ20071512","volume":"412","author":"M Ekerot","year":"2008","unstructured":"Ekerot M, Stavridis MP, Delavaine L, Mitchell MP, Staples C, Owens DM et al. (2008). Negative-feedback regulation of FGF signalling by DUSP6\/MKP-3 is driven by ERK1\/2 and mediated by Ets factor binding to a conserved site within the DUSP6\/MKP-3 gene promoter. Biochem J 412: 287\u2013298.","journal-title":"Biochem J"},{"key":"BFonc2011426_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0006-2952(00)00441-X","volume":"60","author":"KV Ferry","year":"2000","unstructured":"Ferry KV, Hamilton TC, Johnson SW . (2000). Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem Pharmacol 60: 1305\u20131313.","journal-title":"Biochem Pharmacol"},{"key":"BFonc2011426_CR14","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0002-9440(10)64315-5","volume":"162","author":"T Furukawa","year":"2003","unstructured":"Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A . (2003). Potential tumor suppressive pathway involving DUSP6\/MKP-3 in pancreatic cancer. Am J Pathol 162: 1807\u20131815.","journal-title":"Am J Pathol"},{"key":"BFonc2011426_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","volume":"52","author":"FL Graham","year":"1973","unstructured":"Graham FL, van der Eb AJ . (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456\u2013467.","journal-title":"Virology"},{"key":"BFonc2011426_CR16","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/j.1471-4159.2008.05550.x","volume":"106","author":"A Gozdz","year":"2008","unstructured":"Gozdz A, Vashishta A, Kalita K, Szatmari E, Zheng JJ, Tamiya S et al. (2008). Cisplatin-mediated activation of extracellular signal-regulated kinases 1\/2 (ERK1\/2) by inhibition of ERK1\/2 phosphatases. J Neurochem 106: 2056\u20132067.","journal-title":"J Neurochem"},{"key":"BFonc2011426_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.onc.1202367","volume":"18","author":"R Hoshino","year":"1999","unstructured":"Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O et al. (1999). Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 18: 813\u2013822.","journal-title":"Oncogene"},{"key":"BFonc2011426_CR18","first-page":"362","volume":"57","author":"B Jansen","year":"1997","unstructured":"Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI et al. (1997). Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 57: 362\u2013365.","journal-title":"Cancer Res"},{"key":"BFonc2011426_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nature09627","volume":"468","author":"CM Johannessen","year":"2010","unstructured":"Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA et al. (2010). COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468: 968\u2013972.","journal-title":"Nature"},{"key":"BFonc2011426_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0955-0674(94)90141-4","volume":"6","author":"GL Johnson","year":"1994","unstructured":"Johnson GL, Vaillancourt RR . (1994). Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 6: 230\u2013238.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2011426_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.onc.1210700","volume":"27","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P et al. (2008). High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 27: 565\u2013573.","journal-title":"Oncogene"},{"key":"BFonc2011426_CR22","first-page":"3223","volume":"30","author":"K Kirschner","year":"2010","unstructured":"Kirschner K, Melton DW . (2010). Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Anticancer Res 30: 3223\u20133232.","journal-title":"Anticancer Res"},{"key":"BFonc2011426_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bcp.2009.09.024","volume":"79","author":"JC Ko","year":"2010","unstructured":"Ko JC, Su YJ, Lin ST, Jhan JY, Ciou SC, Cheng CM et al. (2010). Suppression of ERCC1 and Rad51 expression through ERK1\/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells. Biochem Pharmacol 79: 655\u2013664.","journal-title":"Biochem Pharmacol"},{"key":"BFonc2011426_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G","volume":"70","author":"B Koberle","year":"1997","unstructured":"Koberle B, Grimaldi KA, Sunters A, Hartley JA, Kelland LR, Masters JR . (1997). DNA repair capacity and cisplatin sensitivity of human testis tumour cells. Int J Cancer 70: 551\u2013555.","journal-title":"Int J Cancer"},{"key":"BFonc2011426_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0960-9822(99)80118-3","volume":"23","author":"B Koberle","year":"1999","unstructured":"Koberle B, Masters JR, Hartley JA, Wood RD . (1999). Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 23: 273\u2013276.","journal-title":"Curr Biol"},{"key":"BFonc2011426_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbamcr.2006.12.002","volume":"1773","author":"K Kondoh","year":"2007","unstructured":"Kondoh K, Nishida E . (2007). Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 1773: 1227\u20131237.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2011426_CR27","doi-asserted-by":"publisher","first-page":"26632","DOI":"10.1074\/jbc.C000337200","volume":"275","author":"I Kuraoka","year":"2000","unstructured":"Kuraoka I, Kobertz WR, Ariza RR, Biggerstaff M, Essigmann JM, Wood RD . (2000). Repair of interstrand DNA crosslink initiated by ERCC1-XPF repair\/recombination nuclease. J Biol Chem 275: 26632\u201326636.","journal-title":"J Biol Chem"},{"key":"BFonc2011426_CR28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","volume":"34","author":"D Lebwohl","year":"1998","unstructured":"Lebwohl D, Canetta R . (1998). Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34: 1522\u20131534.","journal-title":"Eur J Cancer"},{"key":"BFonc2011426_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/bj3310591","volume":"331","author":"W Lee-Kwon","year":"1998","unstructured":"Lee-Kwon W, Park D, Bernier M . (1998). Involvement of the Ras\/extracellular signal-regulated kinase signalling pathway in the regulation of ERCC-1 mRNA levels by insulin. Biochem J 331: 591\u2013597.","journal-title":"Biochem J"},{"key":"BFonc2011426_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402\u2013428.","journal-title":"Methods"},{"key":"BFonc2011426_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","volume":"14","author":"LP Martin","year":"2008","unstructured":"Martin LP, Hamilton TC, Schilder RJ . (2008). Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 14: 1291\u20131295.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011426_CR32","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/sj.jid.5700870","volume":"127","author":"A Mirmohammadsadegh","year":"2007","unstructured":"Mirmohammadsadegh A, Mota R, Gustrau A, Hassan M, Nambiar S, Marini A et al. (2007). ERK1\/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. J Invest Dermatol 127: 2207\u20132215.","journal-title":"J Invest Dermatol"},{"key":"BFonc2011426_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09626","volume":"468","author":"R Nazarian","year":"2010","unstructured":"Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H et al. (2010). Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 468: 973\u2013937.","journal-title":"Nature"},{"key":"BFonc2011426_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/adc.2005.086918","volume":"91","author":"SA Oliveria","year":"2006","unstructured":"Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C . (2006). Sun exposure and risk of melanoma. Arch Dis Child 91: 131\u2013138.","journal-title":"Arch Dis Child"},{"key":"BFonc2011426_CR35","first-page":"1007","volume":"5","author":"DL Persons","year":"1999","unstructured":"Persons DL, Yazlovitskaya EM, Cui W, Pelling JC . (1999). Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5: 1007\u20131014.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011426_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0300-9084(99)80034-0","volume":"81","author":"C Petit","year":"1999","unstructured":"Petit C, Sancar A . (1999). Nucleotide excision repair: from E. coli to man. Biochimie 81: 15\u201325.","journal-title":"Biochimie"},{"key":"BFonc2011426_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME . (2007). Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33: 9\u201323.","journal-title":"Cancer Treat Rev"},{"key":"BFonc2011426_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/107327480301000404","volume":"10","author":"R Rosell","year":"2003","unstructured":"Rosell R, Taron M, Barnadas A, Scagliotti G, Sarries C, Roig B . (2003). Nucleotide excision repair pathways involved in cisplatin resistance in non-small-cell lung cancer. Cancer Control 10: 297\u2013305.","journal-title":"Cancer Control"},{"key":"BFonc2011426_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.dnarep.2010.02.018","volume":"9","author":"J Selfridge","year":"2010","unstructured":"Selfridge J, Song L, Brownstein DG, Melton DW . (2010). Mice with DNA repair gene Ercc1 deficiency in a neural crest lineage are a model for late-onset Hirschsprung disease. DNA Repair 9: 653\u2013660.","journal-title":"DNA Repair"},{"key":"BFonc2011426_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drup.2009.09.001","volume":"12","author":"MM Shahzad","year":"2009","unstructured":"Shahzad MM, Lopez-Berestein G, Sood AK . (2009). Novel strategies for reversing platinum resistance. Drug Resist Updat 12: 148\u2013152.","journal-title":"Drug Resist Updat"},{"key":"BFonc2011426_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11248-010-9396-3","volume":"20","author":"L Song","year":"2011","unstructured":"Song L, Winter AG, Selfridge J, Melton DW . (2011). A novel transcript for DNA repair gene Ercc1 in mouse skin. Transgenic Res 20: 109\u2013122.","journal-title":"Transgenic Res"},{"key":"BFonc2011426_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0006-2952(97)00448-6","volume":"55","author":"C Stecca","year":"1998","unstructured":"Stecca C, Gerber GB . (1998). Adaptive response to DNA-damaging agents: a review of potential mechanisms. Biochem Pharmacol 55: 941\u2013951.","journal-title":"Biochem Pharmacol"},{"key":"BFonc2011426_CR43","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMra041245","volume":"351","author":"H Tsao","year":"2004","unstructured":"Tsao H, Atkins MB, Sober AJ . (2004). Management of cutaneous melanoma. N Engl J Med 351: 998\u20131012.","journal-title":"N Engl J Med"},{"key":"BFonc2011426_CR44","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1093\/nar\/15.22.9195","volume":"15","author":"M van Duin","year":"1987","unstructured":"van Duin M, Koken MH, van den Tol J, ten Dijke P, Odijk H . (1987). Genomic characterization of the human DNA excision repair gene ERCC-1. Nucleic Acids Res 15: 9195\u20139213.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2011426_CR45","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K . (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1: 1112\u20131116.","journal-title":"Nat Protoc"},{"key":"BFonc2011426_CR46","doi-asserted-by":"publisher","first-page":"39435","DOI":"10.1074\/jbc.M004583200","volume":"275","author":"X Wang","year":"2000","unstructured":"Wang X, Martindale JL, Holbrook NJ . (2000). Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435\u201339443.","journal-title":"J Biol Chem"},{"key":"BFonc2011426_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/bj3330291","volume":"333","author":"X Wang","year":"1998","unstructured":"Wang X, Martindale JL, Liu Y, Holbrook NJ . (1998). The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291\u2013300.","journal-title":"Biochem J"},{"key":"BFonc2011426_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ijc.20134","volume":"110","author":"C Welsh","year":"2004","unstructured":"Welsh C, Day R, McGurk C, Masters JR, Wood RD, Koberle B . (2004). Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int J Cancer 110: 352\u2013361.","journal-title":"Int J Cancer"},{"key":"BFonc2011426_CR49","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/sj.onc.1208400","volume":"24","author":"AG Winter","year":"2005","unstructured":"Winter AG, Dorgan C, Melton DW . (2005). Expression of a splicing variant in the 5\u2032-UTR of the human ERCC1 gene is not cancer related. Oncogene 24: 2110\u20132113.","journal-title":"Oncogene"},{"key":"BFonc2011426_CR50","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Z Xia","year":"1995","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326\u20131331.","journal-title":"Science"},{"key":"BFonc2011426_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1667\/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2","volume":"159","author":"A Yacoub","year":"2003","unstructured":"Yacoub A, McKinstry R, Hinman D, Chung T, Dent P, Hagan MP . (2003). Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiat Res 159: 439\u2013452.","journal-title":"Radiat Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011426","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T20:03:53Z","timestamp":1713038633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,26]]},"references-count":51,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,5,10]]}},"alternative-id":["BFonc2011426"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.426","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,26]]},"assertion":[{"value":"29 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}